TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 8841209

Group type: EXPERIMENTAL
Intervention: Propranolol 2 mg IV
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 1365676

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee (100 mg/serving) under forced-choice condition
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee under forced-choice condition
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Caffeinated coffee under free-choice condition
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Decaffeinated coffee under free-choice condition
Number of subjects: 10
Study: 6384434

Group type: EXPERIMENTAL
Intervention: Metronidazole (6 g/m2 given 4 hr before each of the first 3 doses of RT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no metronidazole)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Metronidazole (6 g/m2)
Number of subjects: 0
Study: 31623760

Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I assay with sex-specific thresholds
Number of subjects: 48282
Study: 28521541

Group type: EXPERIMENTAL
Intervention: Tavaborole topical solution, 5%
Number of subjects: 62

Group type: COMPARATOR
Intervention: Vehicle control
Number of subjects: 62
Study: 26955677

Group type: EXPERIMENTAL
Intervention: Tai Ji Quan (TJQ) training
Number of subjects: 60
Study: 24842847

Group type: EXPERIMENTAL
Intervention: Real-time CPR cycles (120s)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Shortened CPR cycles (30-45s)
Number of subjects: 54
Study: 22389634

Group type: COMPARATOR
Intervention: Clean delivery kit use
Number of subjects: 19754

Group type: COMPARATOR
Intervention: Individual clean delivery practices (boiled blade and thread, plastic sheet, gloves, hand washing, appropriate cord care)
Number of subjects: 19754

Group type: COMPARATOR
Intervention: Each additional clean delivery practice used
Number of subjects: 19754
Study: 20849498

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided PNB
Number of subjects: 40

Group type: COMPARATOR
Intervention: Landmark-based technique (LBT)
Number of subjects: 40
Study: 17187609

Group type: EXPERIMENTAL
Intervention: Combination of psychological treatment and physiotherapy (Group A)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Physiotherapy only (Group B)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Integrated combination of psychological treatment and somatic treatment (Group C)
Number of subjects: 83
Study: 15727400

Group type: EXPERIMENTAL
Intervention: Fentanyl (1 mcg/kg) plus midazolam (0.02 mg/kg)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Meperidine (0.5 mg/kg) plus midazolam (0.02 mg/kg)
Number of subjects: 70
Study: 12011785

Group type: EXPERIMENTAL
Intervention: Combined use of dopamine and diltiazem
Number of subjects: 60

Group type: COMPARATOR
Intervention: Dopamine-only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diltiazem-only
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study: 9764096

Group type: EXPERIMENTAL
Intervention: Occupational rehabilitation by occupational physicians
Number of subjects: 0
Study: 7906331

Group type: EXPERIMENTAL
Intervention: Embolectomy
Number of subjects: 37

Group type: COMPARATOR
Intervention: Thrombolysis (alteplase)
Number of subjects: 37
Study: 2527544

Group type: EXPERIMENTAL
Intervention: Cilazapril (2.5 mg day‐1)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Propranolol (120 mg day‐1)
Number of subjects: 23
Study: 12782

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Propranolol (40 mg)
Number of subjects: 10
Study: 31197361

Group type: EXPERIMENTAL
Intervention: 1 x 10^7 bmMSCs (cohort 1, n = 5)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 3 x 10^7 bmMSCs (cohort 2, n = 5)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: 9 x 10^7 bmMSCs (cohort 3, n = 5)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: bmMSC therapy
Number of subjects: 21
Study: 30507632

Group type: EXPERIMENTAL
Intervention: Resolute zotarolimus-eluting stents (R-ZES)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Xience everolimus-eluting stents (EES)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Both R-ZES and EES
Number of subjects: 302
Study: 28087178

Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (bilateral Five Shu in Spleen Meridian), once daily for 10 consecutive days.
Number of subjects: 123

Group type: COMPARATOR
Intervention: Sham treatment (same acupoints using Park Sham Device), once daily for 10 consecutive days.
Number of subjects: 123
Study: 26476417

Group type: EXPERIMENTAL
Intervention: Long course chemoradiotherapy (LC)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Short course radiotherapy (SC)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Surgery alone
Number of subjects: 106

Group type: COMPARATOR
Intervention: Long cue vignettes
Number of subjects: 106

Group type: COMPARATOR
Intervention: Tumour stage, nodal status, tumour position, circumferential location
Number of subjects: 106

Group type: COMPARATOR
Intervention: T4 tumour
Number of subjects: 106
Study: 23288026

Group type: EXPERIMENTAL
Intervention: Delicate surgery and closure by primary intention (Protocol A)
Number of subjects: 700

Group type: EXPERIMENTAL
Intervention: Nontraumatic avulsion and closure by secondary intention (Protocol B)
Number of subjects: 700
Study: 21127910

Group type: EXPERIMENTAL
Intervention: Human Patient Simulator (HPS)
Number of subjects: 18

Group type: COMPARATOR
Intervention: Non-lifelike simulator
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Both training groups
Number of subjects: 18
Study: 19308861

Group type: EXPERIMENTAL
Intervention: Modified regional anaesthetic block technique (single upper arm tourniquet, single forearm tourniquet)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional bier block (double upper arm tourniquet)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Modified regional anaesthetic block technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Traditional bier block
Number of subjects: 20
Study: 17096621

Group type: COMPARATOR
Intervention: Various interventions including counseling, education, self‐medication programs, cues and organizers, and decreasing dosing frequency.
Number of subjects: 57

Group type: COMPARATOR
Intervention: Decreasing dosing frequency and self‐medication programs.
Number of subjects: 57
Study: 14755979

Group type: EXPERIMENTAL
Intervention: Physical exercises 3‐5 times/week, 45‐60 min. per session, combined with antihypertensive drug therapy (Group B)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Antihypertensive drug therapy only (Group C)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Physical exercises and antihypertensive therapy (Group B)
Number of subjects: 80
Study: 10727313

Group type: EXPERIMENTAL
Intervention: 150 mg cyclosporine microemulsion daily
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: 300 mg cyclosporine microemulsion daily
Number of subjects: 106
Study: 9387716

Group type: EXPERIMENTAL
Intervention: Traditional Chinese tonics with strengthened nutrients
Number of subjects: 103
Study: 1552913

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin (0.4 g per kilogram per day)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Plasma exchange (200 to 250 ml per kilogram of body weight)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin
Number of subjects: 150

Group type: COMPARATOR
Intervention: Plasma exchange
Number of subjects: 150
Study: 2933999

Group type: EXPERIMENTAL
Intervention: etomidate + fentanyl
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: flunitrazepam + fentanyl
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: midazolam + fentanyl
Number of subjects: 45
Study: 31053142

Group type: COMPARATOR
Intervention: 3 standard doses of HBV vaccination (20 μg at month 0, 1, 6)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 4 standard doses of HBV vaccination (20 μg at month 0, 1, 2, 6)
Number of subjects: 54

Group type: COMPARATOR
Intervention: 3 standard doses of HBV vaccination
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: 4 standard doses of HBV vaccination
Number of subjects: 54
Study: 29748420

Group type: EXPERIMENTAL
Intervention: Daily remote ischaemic conditioning (rIC) for 4 weeks starting on day 3 post P‐PCI
Number of subjects: 73

Group type: COMPARATOR
Intervention: Sham conditioning
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Daily remote ischaemic conditioning (rIC)
Number of subjects: 73
Study: 28256813

Group type: EXPERIMENTAL
Intervention: BUP-MOR group (3 mg bupivacaine + 50 mcg morphine)
Number of subjects: 66

Group type: COMPARATOR
Intervention: BUP group (5 mg bupivacaine)
Number of subjects: 66
Study: 24732143

Group type: EXPERIMENTAL
Intervention: Moderate-to-vigorous physical activity (MVPA)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Sedentary time (SED-time)
Number of subjects: 231

Group type: EXPERIMENTAL
Intervention: Fat indices
Number of subjects: 231
Study: 23292847

Group type: EXPERIMENTAL
Intervention: Velocity Training (VT)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional Strength Training (ST)
Number of subjects: 16
Study: 21680944

Group type: COMPARATOR
Intervention: Conventional invasive weaning
Number of subjects: 208

Group type: COMPARATOR
Intervention: Standard oxygen therapy
Number of subjects: 208

Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation (NIV)
Number of subjects: 208
Study: 17387332

Group type: EXPERIMENTAL
Intervention: Active nicotine replacement therapy transdermal patch
Number of subjects: 720

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: DRD4 VNTR genotype
Number of subjects: 720

Group type: EXPERIMENTAL
Intervention: DRD4 C-521T genotype
Number of subjects: 720
Study: 17268395

Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Newer M3 receptor selective anticholinergics (solifenacin, darifenacin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Oxybutynin patch
Number of subjects: 0
Study: 12830340

Group type: EXPERIMENTAL
Intervention: Benazepril 10 mg o.d.
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg o.d.
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Benazepril and Amlodipine combination o.d.
Number of subjects: 38
Study: 11273913

Group type: COMPARATOR
Intervention: Total-IV anesthesia (TIVA) with propofol and fentanyl
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Thoracic epidural anesthesia (TEA) combined with general anesthesia (GA) using bupivacaine 0.5% and low-dose isoflurane (0.3-0.5 vol%)
Number of subjects: 50
Study: 9161112

Group type: EXPERIMENTAL
Intervention: Spina bifida health-related quality of life (HRQOL) instrument
Number of subjects: 329
Study: 8510388

Group type: EXPERIMENTAL
Intervention: KCl (80 mmol/day)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 2442323

Group type: EXPERIMENTAL
Intervention: RT plus CT (bleomycin and methotrexate)
Number of subjects: 104

Group type: COMPARATOR
Intervention: RT alone
Number of subjects: 104
Study: 31840248

Group type: EXPERIMENTAL
Intervention: Self-distancing
Number of subjects: 149

Group type: COMPARATOR
Intervention: Self-immersed
Number of subjects: 149
Study: 29715227

Group type: COMPARATOR
Intervention: Closed Reduction and Percutaneous Pinning (CRPP)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Open Reduction and Internal Fixation (ORIF)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall costs
Number of subjects: 40
Study: 30265463

Group type: EXPERIMENTAL
Intervention: Laparoscopic cruroraphy (group I)
Number of subjects: 0
Study: 24993695

Group type: EXPERIMENTAL
Intervention: green-plant membranes (5 g)
Number of subjects: 38

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 38
Study: 22903139

Group type: EXPERIMENTAL
Intervention: Isoload (IL) eccentric resistance training
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Isokinetic (IK) eccentric resistance training
Number of subjects: 31

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 31
Study: 21715226

Group type: EXPERIMENTAL
Intervention: Alzheimer's disease (AD)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Healthy controls (HC)
Number of subjects: 118
Study: 17993663

Group type: EXPERIMENTAL
Intervention: Survey on radon awareness
Number of subjects: 3600
Study: 17252888

Group type: EXPERIMENTAL
Intervention: Twice‐daily atomoxetine
Number of subjects: 85

Group type: COMPARATOR
Intervention: Thrice‐daily methylphenidate
Number of subjects: 85

Group type: EXPERIMENTAL
Intervention: Atomoxetine
Number of subjects: 85

Group type: COMPARATOR
Intervention: Methylphenidate
Number of subjects: 85
Study: 14501737

Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg daily (40 mg twice daily for 12 weeks)
Number of subjects: 683

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 683

Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg daily
Number of subjects: 683
Study: 10843241

Group type: EXPERIMENTAL
Intervention: Chronic renal failure patients
Number of subjects: 6

Group type: COMPARATOR
Intervention: Healthy individuals (control group)
Number of subjects: 6
Study: 9217897

Group type: EXPERIMENTAL
Intervention: Acute insulin-glucose infusion followed by multidose subcutaneous insulin
Number of subjects: 620

Group type: COMPARATOR
Intervention: Control group (no intensive insulin treatment)
Number of subjects: 620
Study: 8403901

Group type: EXPERIMENTAL
Intervention: Copper T-380A IUD
Number of subjects: 2166
Study: 3829934

Group type: EXPERIMENTAL
Intervention: horse‐ALG and horse‐ATG
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: rabbit‐ATG
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cyclosporin A
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: All treatments
Number of subjects: 42
Study: 29477588

Group type: COMPARATOR
Intervention: High-frequency left-sided rTMS (n = 21)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Low-frequency right-sided rTMS (n = 18)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Sequential bilateral rTMS (n = 20)
Number of subjects: 113
Study: 27496229

Group type: EXPERIMENTAL
Intervention: Semi-individualised Chinese medicine treatment for 48 weeks
Number of subjects: 148

Group type: COMPARATOR
Intervention: Standard medical care
Number of subjects: 148
Study: 23836493

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combination of Aerobic and Resistance Training (AT+RT)
Number of subjects: 45
Study: 22449900

Group type: EXPERIMENTAL
Intervention: Use of metal filter in FPD during X-ray exposure
Number of subjects: 40
Study: 20565376

Group type: EXPERIMENTAL
Intervention: Genzyme (Thymoglobulin: ATG‐G; 6.2 +/‐ 2.9 mg/kg for 7 days)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Fresenius (Lymphoglobulin: ATG‐F; 22.6 +/‐ 7.9 mg/kg for 6 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 16
Study: 18988154

Group type: EXPERIMENTAL
Intervention: Azithromycin 1.5% eye-drops, twice daily for 3 days
Number of subjects: 1043

Group type: COMPARATOR
Intervention: Tobramycin 0.3% eye-drops, every 2 hours while awake for 2 days, then four times daily for 5 days
Number of subjects: 1043
Study: 20159729

Group type: EXPERIMENTAL
Intervention: Danqi Huogan Capsule in addition to routine therapies
Number of subjects: 104

Group type: COMPARATOR
Intervention: Routine therapies for liver protection
Number of subjects: 104
Study: 15480740

Group type: EXPERIMENTAL
Intervention: Experimental group (EXP) performing exhaustive SSC exercise
Number of subjects: 6

Group type: COMPARATOR
Intervention: Control group (C) not performing SSC exercise
Number of subjects: 6
Study: 12399262

Group type: EXPERIMENTAL
Intervention: Fat-substituted diet (one-third of dietary fat replaced by olestra to achieve a diet containing 25% metabolizable fat)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control diet (33% fat)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Fat-reduced diet (25% fat)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Comparison between fat-reduced and fat-substituted groups
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Comparison between control and fat-substituted groups
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Comparison between control and fat-reduced groups
Number of subjects: 45
Study: 9538773

Group type: EXPERIMENTAL
Intervention: Urine collection pads
Number of subjects: 0

Group type: COMPARATOR
Intervention: Clean-catch method using sterile foil bowls
Number of subjects: 0
Study: 8005276

Group type: EXPERIMENTAL
Intervention: Depot form of triptoreline (3.75 mg IM injection)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Standard release form of triptoreline (0.1 mg SC daily)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Both groups (Depot and Standard release)
Number of subjects: 196
Study: 2688533

Group type: EXPERIMENTAL
Intervention: Iopromide 300 (brain) and 370 (whole body)
Number of subjects: 165

Group type: COMPARATOR
Intervention: Ioxaglate 320
Number of subjects: 165
Study: 4215536

Group type: EXPERIMENTAL
Intervention: Slow-release iron
Number of subjects: 28

Group type: COMPARATOR
Intervention: Ferrous sulphate
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Ascorbic acid
Number of subjects: 28
Study: 11726845

Group type: EXPERIMENTAL
Intervention: Sodium phosphate tablets
Number of subjects: 845

Group type: COMPARATOR
Intervention: PEG solution
Number of subjects: 845
Study: 31300667

Group type: EXPERIMENTAL
Intervention: Micronutrient treatment
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 30126094

Group type: EXPERIMENTAL
Intervention: Kiwifruit preload
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rice-split preload
Number of subjects: 0

Group type: COMPARATOR
Intervention: Rice meal in one sitting
Number of subjects: 0
Study: 27084279

Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) + photodynamic therapy + oral hygiene (OH)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Scaling and root planing (SRP) + oral hygiene (OH)
Number of subjects: 182
Study: 25276785

Group type: EXPERIMENTAL
Intervention: Combined home exercise (COMB)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Range-of-motion home exercise (ROM)
Number of subjects: 19
Study: 22797283

Group type: EXPERIMENTAL
Intervention: Magnesium lozenges, administered 30 min preoperatively.
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (control group), administered 30 min preoperatively.
Number of subjects: 70
Study: 21200437

Group type: EXPERIMENTAL
Intervention: Telmisartan (80 mg/day)
Number of subjects: 25620

Group type: COMPARATOR
Intervention: Ramipril (10 mg/day)
Number of subjects: 25620

Group type: EXPERIMENTAL
Intervention: Telmisartan
Number of subjects: 25620

Group type: COMPARATOR
Intervention: Ramipril
Number of subjects: 25620
Study: 17526320

Group type: EXPERIMENTAL
Intervention: Community health education, mass media interventions, training of health professionals, health education through Lady Health Workers
Number of subjects: 0

Group type: COMPARATOR
Intervention: Training of health care providers
Number of subjects: 0
Study: 16003289

Group type: EXPERIMENTAL
Intervention: St John's wort (SJW) 300 mg LI 160 3 times daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control (no SJW)
Number of subjects: 16
Study: 12462291

Group type: EXPERIMENTAL
Intervention: Interferon alpha-n2b (5 MU subcutaneously once daily for 8 weeks, then 5 MU TIW for 48 weeks if HCV-RNA negative)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (males without a history of drug addiction)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Interferon alpha-n2b (for heroin abusers)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cytokine levels and activated CD11 antigen-expressing monocytes (for heroin abusers)
Number of subjects: 60
Study: 10528972

Group type: EXPERIMENTAL
Intervention: Amalgam
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Resin composite
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Resin-modified glass ionomer cement
Number of subjects: 49
Study: 7473014

Group type: EXPERIMENTAL
Intervention: Scaling and root planing plus tetracycline fiber for 10 days (SF)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Scaling and root planing (S)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Fiber therapy alone for 10 days (F)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Fiber therapy alone for 20 days (FF)
Number of subjects: 122
Study: 1782132

Group type: EXPERIMENTAL
Intervention: Aggressive dietary management and treatment with pancreatic enzymes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Males with cystic fibrosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Careful observation for nutritional abnormalities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attention to vitamin E and essential fatty acid status
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term consequences of early nutritional intervention
Number of subjects: 0
Study: 7025721

Group type: EXPERIMENTAL
Intervention: Oral trimethoprim-sulfamethoxazole treatment
Number of subjects: 29

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 29
Study: 31376708

Group type: EXPERIMENTAL
Intervention: Computerized sequenced Attention Bias Modification (ABM) followed by Applied Relaxation psychoeducation (AR‐pe)
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Reversed sequence of AR‐pe and ABM
Number of subjects: 169

Group type: EXPERIMENTAL
Intervention: Simultaneous ABM and AR‐pe
Number of subjects: 169

Group type: COMPARATOR
Intervention: Assessment only control group
Number of subjects: 169
Study: 29031023

Group type: EXPERIMENTAL
Intervention: Whole-body vibration combined with treadmill training (WBV-TT)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Treadmill training (TT)
Number of subjects: 30
Study: 26061572

Group type: EXPERIMENTAL
Intervention: Benzocaine 20% topical anesthetic
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study: 24343322

Group type: EXPERIMENTAL
Intervention: Specific stabilization exercise (SSE)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: General stabilization exercise (GSE)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Combined groups (SSE and GSE)
Number of subjects: 11
Study: 23036123

Group type: EXPERIMENTAL
Intervention: Kinesitherapy
Number of subjects: 35